By Joseph Walker

Amgen is laying off about 350 U.S. employees of Horizon Therapeutics, the drugmaker that Amgen bought in a $27.8 billion deal that closed earlier this month.

Most of the cuts are for jobs that overlap with existing Amgen jobs, an Amgen spokeswoman tells Dow Jones Newswires.

Amgen is retaining more than 80% of Horizon's U.S. workforce, "reflecting the knowledge and capabilities we need to continue serving patients suffering from rare diseases," the spokeswoman said.

Horizon had a total workforce of 2,190 people as of June 30, according to regulatory filings.

Write to Joseph Walker at joseph.walker@wsj.com

(END) Dow Jones Newswires

October 24, 2023 13:05 ET (17:05 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Amgen (NASDAQ:AMGN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Amgen.
Amgen (NASDAQ:AMGN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Amgen.